Artikel ; Online: A Case of Acute Retinal Necrosis Associated with Reactivation of Varicella Zoster Virus after COVID-19 Vaccination.
Ocular immunology and inflammation
2021 Band 31, Heft 1, Seite(n) 233–235
Abstract: Purpose: To report a case of acute retinal necrosis (ARN) after receiving COVID-19 vaccination.: Methods: A case report.: Results: A 78-year-old man complained of blurred vision and floaters in the right eye 2 days after receiving BNT162b2 mRNA- ... ...
Abstract | Purpose: To report a case of acute retinal necrosis (ARN) after receiving COVID-19 vaccination. Methods: A case report. Results: A 78-year-old man complained of blurred vision and floaters in the right eye 2 days after receiving BNT162b2 mRNA-based COVID-19 vaccine and was referred to our hospital with worsening visual acuity after 7 days. He had no systemic symptoms and no history of systemic diseases. Ophthalmic examination revealed white-yellowish placoid lesions spreading to the entire circumference of the retina, and temporal and upper lesions extending to the posterior pole, although anterior inflammation and vitreous opacity were mild. Diagnostic and therapeutic vitrectomy was performed, and VZV-DNA was detected by comprehensive PCR using a vitreous fluid sample. The ocular inflammation subsided by systemic administration of antivirals and corticosteroids. However, total retinal detachment requiring repeat vitrectomy using silicone oil occurred after the second vaccination. Conclusion: ARN associated with VZV reactivation may develop after SARS-CoV-2 mRNA vaccination. |
---|---|
Mesh-Begriff(e) | Aged ; Humans ; Male ; BNT162 Vaccine ; COVID-19/diagnosis ; COVID-19/complications ; COVID-19 Vaccines/adverse effects ; Herpes Zoster Ophthalmicus/diagnosis ; Herpes Zoster Ophthalmicus/drug therapy ; Herpes Zoster Ophthalmicus/etiology ; Herpesvirus 3, Human/genetics ; Inflammation/complications ; Retinal Necrosis Syndrome, Acute/diagnosis ; Retinal Necrosis Syndrome, Acute/drug therapy ; Retinal Necrosis Syndrome, Acute/etiology ; SARS-CoV-2 |
Chemische Substanzen | BNT162 Vaccine ; COVID-19 Vaccines |
Sprache | Englisch |
Erscheinungsdatum | 2021-11-22 |
Erscheinungsland | England |
Dokumenttyp | Case Reports ; Journal Article |
ZDB-ID | 1193873-0 |
ISSN | 1744-5078 ; 0927-3948 |
ISSN (online) | 1744-5078 |
ISSN | 0927-3948 |
DOI | 10.1080/09273948.2021.2001541 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 4004: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.